Warning letterFDA · Sep 7, 2021
Radhanite, LLC d/b/a Curalife Ltd MARCS-CMS 614542, September 07, 2021
Named company: Radhanite, LLC d/b/a Curalife Ltd
A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, CuraLin, fails to bear adequate directions for…
